Enovix’s (ENVX) “Overweight” Rating Reaffirmed at Cantor Fitzgerald

Cantor Fitzgerald reiterated their overweight rating on shares of Enovix (NASDAQ:ENVXFree Report) in a research report released on Thursday, Benzinga reports. Cantor Fitzgerald currently has a $30.00 price target on the stock.

Separately, Canaccord Genuity Group reissued a buy rating and issued a $17.00 target price on shares of Enovix in a report on Wednesday, February 21st. One analyst has rated the stock with a hold rating and six have assigned a buy rating to the company. According to MarketBeat.com, the company currently has an average rating of Moderate Buy and an average price target of $27.43.

View Our Latest Report on Enovix

Enovix Price Performance

NASDAQ ENVX opened at $6.46 on Thursday. Enovix has a 12 month low of $5.70 and a 12 month high of $23.90. The company has a debt-to-equity ratio of 0.65, a current ratio of 5.30 and a quick ratio of 5.15. The stock’s fifty day moving average price is $8.18 and its 200-day moving average price is $10.10.

Enovix (NASDAQ:ENVXGet Free Report) last announced its quarterly earnings data on Tuesday, February 20th. The company reported ($0.35) EPS for the quarter, missing the consensus estimate of ($0.34) by ($0.01). The firm had revenue of $7.38 million for the quarter, compared to analysts’ expectations of $3.37 million. Enovix had a negative net margin of 2,800.51% and a negative return on equity of 77.74%. On average, sell-side analysts expect that Enovix will post -1.13 earnings per share for the current year.

Insiders Place Their Bets

In other news, COO Ajay Marathe sold 4,954 shares of the stock in a transaction on Sunday, April 14th. The stock was sold at an average price of $7.31, for a total transaction of $36,213.74. Following the transaction, the chief operating officer now directly owns 978,913 shares of the company’s stock, valued at approximately $7,155,854.03. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. 17.30% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of ENVX. Allspring Global Investments Holdings LLC bought a new stake in shares of Enovix during the 3rd quarter valued at about $31,000. Beacon Capital Management LLC grew its position in Enovix by 66.7% during the fourth quarter. Beacon Capital Management LLC now owns 2,500 shares of the company’s stock valued at $31,000 after buying an additional 1,000 shares during the period. Carmel Capital Partners LLC bought a new stake in Enovix during the third quarter valued at approximately $34,000. Able Wealth Management LLC purchased a new stake in Enovix during the fourth quarter valued at approximately $34,000. Finally, Quest Partners LLC bought a new position in Enovix in the fourth quarter worth approximately $49,000. Institutional investors own 50.92% of the company’s stock.

About Enovix

(Get Free Report)

Enovix Corporation designs, develops, and manufactures lithium-ion batteries. It serves wearables and IoT, smartphone, laptops and tablets, industrial and medical, and electric vehicles industries. The company was founded in 2007 and is headquartered in Fremont, California.

Featured Articles

Analyst Recommendations for Enovix (NASDAQ:ENVX)

Receive News & Ratings for Enovix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enovix and related companies with MarketBeat.com's FREE daily email newsletter.